ZA978087B - Pharmaceuticals - Google Patents
PharmaceuticalsInfo
- Publication number
- ZA978087B ZA978087B ZA978087A ZA978087A ZA978087B ZA 978087 B ZA978087 B ZA 978087B ZA 978087 A ZA978087 A ZA 978087A ZA 978087 A ZA978087 A ZA 978087A ZA 978087 B ZA978087 B ZA 978087B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceuticals
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Optical Couplings Of Light Guides (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9618967.5A GB9618967D0 (en) | 1996-09-11 | 1996-09-11 | Pharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA978087B true ZA978087B (en) | 1999-03-09 |
Family
ID=10799764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA978087A ZA978087B (en) | 1996-09-11 | 1997-09-09 | Pharmaceuticals |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6331631B1 (cs) |
| EP (1) | EP0927163B1 (cs) |
| JP (2) | JP3748570B2 (cs) |
| KR (1) | KR100525703B1 (cs) |
| CN (1) | CN1102927C (cs) |
| AR (1) | AR008174A1 (cs) |
| AT (1) | ATE358121T1 (cs) |
| AU (1) | AU725210B2 (cs) |
| BR (1) | BR9712014A (cs) |
| CA (1) | CA2266468C (cs) |
| CO (1) | CO4930263A1 (cs) |
| CY (1) | CY2590B2 (cs) |
| CZ (1) | CZ290932B6 (cs) |
| DE (1) | DE69737529T2 (cs) |
| DK (1) | DK0927163T3 (cs) |
| ES (1) | ES2285732T3 (cs) |
| GB (1) | GB9618967D0 (cs) |
| HK (1) | HK1020963A1 (cs) |
| HU (1) | HUP9904155A3 (cs) |
| IL (1) | IL128785A0 (cs) |
| NO (1) | NO312587B1 (cs) |
| NZ (1) | NZ334272A (cs) |
| PL (1) | PL191373B1 (cs) |
| PT (1) | PT927163E (cs) |
| SA (1) | SA97180387B1 (cs) |
| SI (1) | SI0927163T1 (cs) |
| TR (1) | TR199900493T2 (cs) |
| TW (1) | TW432048B (cs) |
| WO (1) | WO1998011067A1 (cs) |
| ZA (1) | ZA978087B (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9618967D0 (en) * | 1996-09-11 | 1996-10-23 | Smithkline Beecham Plc | Pharmaceuticals |
| US20020091271A1 (en) | 1998-07-16 | 2002-07-11 | Smithkline Beecham Plc | Process for the preparation of an indole derivative |
| GB0211230D0 (en) | 2002-05-16 | 2002-06-26 | Medinnova Sf | Treatment of heart failure |
| CN104557672B (zh) * | 2015-01-26 | 2016-09-21 | 湖南华腾制药有限公司 | 一种1位取代哌啶衍生物的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5821904B2 (ja) * | 1975-04-04 | 1983-05-04 | 住友化学工業株式会社 | シンキナメタノ−アントラセンユウドウタイノセイゾウホウホウ |
| ZA899436B (en) * | 1988-12-12 | 1990-08-29 | Ciba Geigy | Piperidine derivatives |
| AT394715B (de) * | 1990-08-14 | 1992-06-10 | Chemie Linz Gmbh | Verfahren zur n-alkylierung von harnstoffen |
| CZ283619B6 (cs) * | 1991-09-12 | 1998-05-13 | Smithkline Beecham P.L.C | Použití derivátů kyseliny benzoové pro výrobu farmaceutických prostředků, deriváty kyseliny benzoo vé, způsob jejich výroby a farmaceutické prostředky s jejich obsahem |
| MA22647A1 (fr) * | 1991-09-14 | 1993-04-01 | Smithkline Beecham Plc | Procede de preparation d'un ester ou d'un amide d'un nouveau produit . |
| DE69325167T2 (de) * | 1992-03-12 | 2000-01-20 | Smithkline Beecham P.L.C., Brentford | Kondensierte indol-derivate als 5-ht4-rezeptor-antagonisten |
| GB9209687D0 (en) * | 1992-05-06 | 1992-06-17 | Smithkline Beecham Plc | Novel process |
| WO1994008965A1 (en) * | 1992-10-16 | 1994-04-28 | Smithkline Beecham Plc | N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists |
| DE4427836A1 (de) * | 1994-08-05 | 1996-02-08 | Hoechst Ag | Verbindungen aus der Reihe der Phosphane, Verfahren zu ihrer Herstellung sowie ihre Verwendung |
| EP0829474B1 (en) | 1995-05-31 | 2003-04-09 | Nisshin Seifun Group Inc. | Indazole derivatives having monocyclic amino group |
| GB9618967D0 (en) * | 1996-09-11 | 1996-10-23 | Smithkline Beecham Plc | Pharmaceuticals |
-
1996
- 1996-09-11 GB GBGB9618967.5A patent/GB9618967D0/en active Pending
-
1997
- 1997-09-04 CO CO97051291A patent/CO4930263A1/es unknown
- 1997-09-09 DK DK97910322T patent/DK0927163T3/da active
- 1997-09-09 NZ NZ334272A patent/NZ334272A/xx unknown
- 1997-09-09 SI SI9730763T patent/SI0927163T1/sl unknown
- 1997-09-09 AT AT97910322T patent/ATE358121T1/de active
- 1997-09-09 AU AU47764/97A patent/AU725210B2/en not_active Ceased
- 1997-09-09 IL IL12878597A patent/IL128785A0/xx not_active IP Right Cessation
- 1997-09-09 ZA ZA978087A patent/ZA978087B/xx unknown
- 1997-09-09 TR TR1999/00493T patent/TR199900493T2/xx unknown
- 1997-09-09 BR BR9712014A patent/BR9712014A/pt active Search and Examination
- 1997-09-09 CA CA002266468A patent/CA2266468C/en not_active Expired - Fee Related
- 1997-09-09 DE DE69737529T patent/DE69737529T2/de not_active Expired - Lifetime
- 1997-09-09 AR ARP970104108A patent/AR008174A1/es active IP Right Grant
- 1997-09-09 PL PL332088A patent/PL191373B1/pl not_active IP Right Cessation
- 1997-09-09 HU HU9904155A patent/HUP9904155A3/hu unknown
- 1997-09-09 EP EP97910322A patent/EP0927163B1/en not_active Expired - Lifetime
- 1997-09-09 PT PT97910322T patent/PT927163E/pt unknown
- 1997-09-09 CN CN97197756A patent/CN1102927C/zh not_active Expired - Fee Related
- 1997-09-09 KR KR10-1999-7001990A patent/KR100525703B1/ko not_active IP Right Cessation
- 1997-09-09 JP JP51328398A patent/JP3748570B2/ja not_active Expired - Fee Related
- 1997-09-09 WO PCT/EP1997/005167 patent/WO1998011067A1/en active IP Right Grant
- 1997-09-09 ES ES97910322T patent/ES2285732T3/es not_active Expired - Lifetime
- 1997-09-09 CZ CZ1999809A patent/CZ290932B6/cs not_active IP Right Cessation
- 1997-09-10 SA SA97180387A patent/SA97180387B1/ar unknown
- 1997-09-10 TW TW086113072A patent/TW432048B/zh not_active IP Right Cessation
-
1999
- 1999-03-10 NO NO19991148A patent/NO312587B1/no not_active IP Right Cessation
-
2000
- 2000-01-04 HK HK00100041A patent/HK1020963A1/xx not_active IP Right Cessation
- 2000-08-22 US US09/643,644 patent/US6331631B1/en not_active Expired - Fee Related
-
2004
- 2004-12-28 JP JP2004380260A patent/JP2005220126A/ja active Pending
-
2008
- 2008-02-29 CY CY0800005A patent/CY2590B2/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9615202D0 (en) | Pharmaceuticals | |
| GB9601544D0 (en) | Pharmaceuticals | |
| EG23684A (en) | Pharmaceuticals | |
| ZA978087B (en) | Pharmaceuticals | |
| GB9606745D0 (en) | Pharmaceuticals | |
| GB9624801D0 (en) | Pharmaceuticals | |
| GB9610909D0 (en) | Pharmaceuticals | |
| GB9615251D0 (en) | Pharmaceuticals | |
| GB9615252D0 (en) | Pharmaceuticals | |
| GB9604909D0 (en) | Pharmaceuticals | |
| GB9604671D0 (en) | Pharmaceuticals | |
| GB9612937D0 (en) | Pharmaceuticals | |
| GB9604453D0 (en) | Pharmaceuticals | |
| GB9612936D0 (en) | Pharmaceuticals | |
| GB9612935D0 (en) | Pharmaceuticals | |
| GB9612939D0 (en) | Pharmaceuticals | |
| GB9604447D0 (en) | Pharmaceuticals | |
| GB9615253D0 (en) | Pharmaceuticals | |
| GB9615274D0 (en) | Pharmaceuticals | |
| GB9624784D0 (en) | Pharmaceuticals | |
| GB9602403D0 (en) | Pharmaceuticals | |
| GB9615272D0 (en) | Pharmaceuticals | |
| GB9615273D0 (en) | Pharmaceuticals | |
| GB9621183D0 (en) | Pharmaceuticals | |
| GB9612938D0 (en) | Pharmaceuticals |